Relmada Therapeutics, Inc. (RLMD)
4.76
+0.23
(+5.08%)
USD |
NASDAQ |
Dec 31, 13:50
Relmada Therapeutics Shareholders Equity (Quarterly): 9.466M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 230.42M |
| Invivyd, Inc. | 93.07M |
| Arcellx, Inc. | 440.78M |
| Puma Biotechnology, Inc. | 115.27M |
| Sensus Healthcare, Inc. | 51.19M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.88M |
| Total Liabilities (Quarterly) | 5.411M |
| Current Ratio | 2.862 |